Evonik Industries (FRA:EVK) received a €31.00 ($36.90) target price from research analysts at Nord/LB in a research report issued on Friday, December 8th. The brokerage presently has a “neutral” rating on the stock. Nord/LB’s target price would suggest a potential downside of 0.48% from the stock’s current price.
EVK has been the subject of several other reports. Commerzbank set a €33.00 ($39.29) price target on Evonik Industries and gave the company a “buy” rating in a research report on Monday, September 18th. Kepler Capital Markets set a €31.00 ($36.90) price objective on Evonik Industries and gave the company a “neutral” rating in a research report on Friday, November 3rd. Barclays set a €35.50 ($42.26) price objective on Evonik Industries and gave the stock a “buy” rating in a research note on Monday, November 6th. DZ Bank reissued a “neutral” rating on shares of Evonik Industries in a report on Monday, October 2nd. Finally, JPMorgan Chase & Co. set a €25.00 ($29.76) price objective on Evonik Industries and gave the company a “sell” rating in a report on Tuesday, November 14th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of €33.75 ($40.18).
Evonik Industries (FRA EVK) traded down €0.18 ($0.21) during midday trading on Friday, hitting €31.19 ($37.13). 354,068 shares of the company traded hands. Evonik Industries has a 1 year low of €26.78 ($31.88) and a 1 year high of €32.97 ($39.25). The company has a market cap of $14,730.00 and a price-to-earnings ratio of 19.87.
ILLEGAL ACTIVITY WARNING: “Nord/LB Analysts Give Evonik Industries (EVK) a €31.00 Price Target” was published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.truebluetribune.com/2018/01/02/nord-lb-reiterates-31-00-price-target-for-evonik-industries-evk.html.
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.